Metraipolis › archive › dc_0505dfcd4f17

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study — Europe PMC PMID:41379803

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41379803
DOI
10.1371/journal.pone.0331163
License (as archived)
solo-consultazione
Archived
2026-11-07T17:49:22.907Z
SHA-256 of the archived text
a5a3039bcf475938eccbf003c539c6549f59d4c958a36056984c873186639110
Stable URL of this page
https://metraipolis.com/documento/dc_0505dfcd4f17

How to cite

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study — Europe PMC PMID:41379803 — Europe PMC (en), https://europepmc.org/article/MED/41379803 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0505dfcd4f17 (Metraipolis archive dc_0505dfcd4f17, sha256 a5a3039bcf475938eccbf003c539c6549f59d4c958a36056984c873186639110)
BibTeX
@misc{dc0505dfcd4f17,
  title = {Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study — Europe PMC PMID:41379803},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41379803},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0505dfcd4f17; sha256 a5a3039bcf475938eccbf003c539c6549f59d4c958a36056984c873186639110},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41379803. Agents can read the archived copy with the MCP tool read_document.